The prognostic importance of prostate specific antigen in the monitorisation of patients undergoing maximum androgen blockade for metastatic prostate cancer-Reference-Cited by-同舟云学术

The prognostic importance of prostate specific antigen in the monitorisation of patients undergoing maximum androgen blockade for metastatic prostate cancer

Published:2006-12-13 Issue:3-4 Volume:38 Page:571-576
ISSN:0301-1623
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Kiper Ahmet,Yiğitbası Orhan,Imamoglu Abdurrahim,Tuygun Can,Turan Celaleddin

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

http://link.springer.com/content/pdf/10.1007/s11255-006-0096-0.pdf

Reference12 articles.

1. Schubert J, Kowalik S (1994) The value of prognostic factors in prostatic cancer. Int Urol Nephrol 26:541–547

2. Kelly WK, Scher HI, Mazumdar M et al (1993) Prostate specific antigen as a measure of disease outcome in metastatic hormone refractory prostate cancer. J Clin Oncol 11:607–615

3. McCormack RT, Rittenhause HG, Finlay JA et al (1995) Molecular forms of prostate specific antigen and the human kallirein gene family: a new era. Urology 45:729–744

4. Arai Y, Yoshiki T, Yoshida O (1990) Prognostic significance of prostate specific antigen in endocrine treatment for prostatic cancer. J Urol 144:1415–1419

5. Matzkin H, Eber P, Todd B et al (1992) Prognostic significance of change in prostate specific antigen markers after endocrine treatment of stage D2 prostatic cancer. Cancer 70:2302–2309

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of nadir PSA value and time to nadir PSA in patients with metastatic castration-naive prostate cancer receiving first-line hormonotherapy;Journal of Cancer Research and Therapeutics;2023-12-15

2. Absolute Prostate Specific Antigen after 6 Months of Androgen Deprivation Therapy Is a Predictor of Overall and Cancer-Specific Mortality in Men with Hormone-Sensitive Prostate Cancer;Journal of Urology;2022-08

3. Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer;BMC Urology;2014-04-29

4. Prostate cancer;The Lancet;2008-05